SMT201500068B - Nuovi analoghi di piperazina come antivirali ad ampio spettro per l'influenza - Google Patents

Nuovi analoghi di piperazina come antivirali ad ampio spettro per l'influenza

Info

Publication number
SMT201500068B
SMT201500068B SM201500068T SM201500068T SMT201500068B SM T201500068 B SMT201500068 B SM T201500068B SM 201500068 T SM201500068 T SM 201500068T SM 201500068 T SM201500068 T SM 201500068T SM T201500068 B SMT201500068 B SM T201500068B
Authority
SM
San Marino
Prior art keywords
influenza
piperazine
broad
new analogues
spectrum antivirals
Prior art date
Application number
SM201500068T
Other languages
English (en)
Italian (it)
Inventor
Christopher W Cianci
Samuel Gerritz
Guo Li
Bradley C Pearce
Annapuma Pendri
Shuhao Shi
Weixu Zhai
Shirong Zhu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SMT201500068B publication Critical patent/SMT201500068B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SM201500068T 2010-09-08 2015-03-18 Nuovi analoghi di piperazina come antivirali ad ampio spettro per l'influenza SMT201500068B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38072810P 2010-09-08 2010-09-08
PCT/US2011/050504 WO2012033736A1 (en) 2010-09-08 2011-09-06 Novel piperazine analogs as broad-spectrum influenza antivirals

Publications (1)

Publication Number Publication Date
SMT201500068B true SMT201500068B (it) 2015-05-05

Family

ID=44653573

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500068T SMT201500068B (it) 2010-09-08 2015-03-18 Nuovi analoghi di piperazina come antivirali ad ampio spettro per l'influenza

Country Status (17)

Country Link
US (1) US8362004B2 (enExample)
EP (1) EP2614052B1 (enExample)
JP (1) JP5902172B2 (enExample)
CN (1) CN103201268B (enExample)
BR (1) BR112013005552A2 (enExample)
CA (1) CA2809624A1 (enExample)
DK (1) DK2614052T3 (enExample)
EA (1) EA023258B1 (enExample)
ES (1) ES2533068T3 (enExample)
HR (1) HRP20150228T1 (enExample)
MX (1) MX2013002557A (enExample)
PL (1) PL2614052T3 (enExample)
PT (1) PT2614052E (enExample)
RS (1) RS53844B1 (enExample)
SI (1) SI2614052T1 (enExample)
SM (1) SMT201500068B (enExample)
WO (1) WO2012033736A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
JP6293770B2 (ja) * 2012-11-05 2018-03-14 ナント ホールディングス アイピー,エルエルシー ヘッジホッグシグナル伝達経路阻害剤としての環状スルホンアミド含有誘導体
KR102089122B1 (ko) * 2016-08-25 2020-03-13 주식회사 엘지화학 디아민 화합물 및 이를 이용하여 제조된 플렉시블 소자용 기판
US11040963B2 (en) 2017-02-02 2021-06-22 Janssen Vaccines & Prevention B.V. Piperazine derivatives for influenza virus inhibitions
WO2018141854A1 (en) 2017-02-02 2018-08-09 Janssen Vaccines & Prevention B.V. Piperazine derivatives for influenza virus inhibition
WO2021204923A1 (en) * 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents
WO2021204924A1 (en) * 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) * 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
ATE323702T1 (de) 2002-08-06 2006-05-15 Astrazeneca Ab Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
AU2004218260A1 (en) 2003-01-28 2004-09-16 Aventis Pharma S.A. N-aryl heteroaromatic products, compositions containing same and use thereof
US6949865B2 (en) * 2003-01-31 2005-09-27 Betabatt, Inc. Apparatus and method for generating electrical current from the nuclear decay process of a radioactive material
GB0428235D0 (en) 2004-12-23 2005-01-26 Glaxo Group Ltd Novel compounds
EP1834954A1 (en) * 2006-03-15 2007-09-19 4Sc Ag Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
RU2012104214A (ru) * 2009-08-05 2013-09-10 Верситек Лимитед Противовирусные соединения и способы их получения и применения

Also Published As

Publication number Publication date
ES2533068T3 (es) 2015-04-07
BR112013005552A2 (pt) 2016-05-03
WO2012033736A1 (en) 2012-03-15
CA2809624A1 (en) 2012-03-15
HRP20150228T1 (hr) 2015-04-10
US8362004B2 (en) 2013-01-29
SI2614052T1 (sl) 2015-04-30
US20120238539A1 (en) 2012-09-20
JP5902172B2 (ja) 2016-04-13
EA201390362A1 (ru) 2013-07-30
EP2614052B1 (en) 2014-12-31
DK2614052T3 (en) 2015-04-07
RS53844B1 (sr) 2015-08-31
EA023258B1 (ru) 2016-05-31
CN103201268B (zh) 2015-08-12
CN103201268A (zh) 2013-07-10
EP2614052A1 (en) 2013-07-17
JP2013537193A (ja) 2013-09-30
MX2013002557A (es) 2013-05-28
PL2614052T3 (pl) 2015-06-30
PT2614052E (pt) 2015-03-31

Similar Documents

Publication Publication Date Title
IT1401129B1 (it) Processo per la sintesi di composti benzotiadiazolici
EP2581431A4 (en) AEROSOL COMPOSITION
EP2819610A4 (en) DETERMINATION OF ANATOMICAL EQUIPMENT
EP2585610A4 (en) pATHOGEN DETECTION
EP2678269A4 (en) AZEOTROPE AND AZEOTROPARTIC COMPOSITIONS SUITABLE FOR THE PREPARATION OF HALO-OLEFINES
EP2844171A4 (en) OUTPUT OF FASTENERS
SI2614052T1 (sl) Novi analogi piperazina kot širokospektralna protivirusna sredstva proti gripi
ITMI20110464A1 (it) Nuovo procedimento per la preparazione di erlotinib
EP2692715A4 (en) COMPOSITION OF GAS-PRODUCING AGENTS
IT1404801B1 (it) "macchina di formatura per la produzione di parti stampate"
IT1405996B1 (it) Procedimento per la preparazione di 2,5-diaminotoluolo
EP2579872A4 (en) HAMMER OF ACT ACTIVITY
ME02008B (me) Sublingvalna formulacija spreja koja sadrži dihidroartemezinin
EP2738168A4 (en) AMID DERIVATIVE WITH SUBSTITUTED N-HETERO RING
FR2967164B1 (fr) Procede de preparation de compositions a base de polypentosides
EP2702991A4 (en) COMPOSITION OF ENTACOPONE
AP2014007945A0 (en) Use of derivative compounds of 1,3-benzodioxole ininsecticidal compositions
IT1400278B1 (it) Procedimento per la fabbricazione di manufatti sinterizzati
IT1400485B1 (it) Nuovo processo per la preparazione dell'aminaftone
EP2663322A4 (en) NEW USES OF CYCLOPHILINE INHIBITORS
IT1398542B1 (it) Processo per la preparazione di un polimorfo
IT1398005B1 (it) Telaio strutturale per la realizzazione di contropareti
IT1394987B1 (it) Procedimento per la preparazione di cinacalcet
SM201000062B (it) Processo per la preparazione di gabapentin
IT1403645B1 (it) Teca per opere d'arte